Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy.

Annals of hematology

Volumn 91, Issue 1, 2012, Pages 115-121

  Kang, Cheol In ^a   Chung, Doo Ryeon ^b   Ko, Kwan Soo ^b   Peck, Kyong Ran ^b   Song, Jae Hoon ^b   Korean Network for Study of Infectious Diseases, ^b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAMASE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BLOOD; BLOOD DISEASE; CROSS INFECTION; DRUG EFFECT; ENZYMOLOGY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; HUMAN; KLEBSIELLA INFECTION; KLEBSIELLA PNEUMONIAE; MALE; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MORTALITY; PATHOGENICITY; RISK FACTOR; TREATMENT OUTCOME;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAMASES; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RISK FACTORS; TREATMENT OUTCOME;

EID: 84857375975     PISSN: None     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-011-1247-7     Document Type: Article

References (0)